Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Pig skin is a good substitute for human skin to measure drug absorption, but differences in skin structure and enzymes across species must be considered.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Jaw wiring helps with weight loss but long-term habits are needed to keep it off.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

The most common causes of hair loss in children in South-East Nigeria are fungal infections and alopecia areata.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

People with alopecia areata have higher insulin resistance.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Women with different PCOS types have similar fertility treatment results.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Adult offspring of sperm donation generally feel positive about their conception and view the donor as their biological father.

Early hair loss may be linked to metabolic syndrome.

Older people in Kerala often have skin conditions, with dry skin being the most common, and certain skin issues are linked to high cholesterol and diabetes.